{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:52:40Z","timestamp":1781772760073,"version":"3.54.5"},"reference-count":37,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Toxic epidermal necrolysis (TEN) is a rare but life-threatening complication that may occur in patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT), particularly in the context of extensive drug exposure. In this population, TEN can closely resemble severe acute graft-versus-host disease (GVHD), making diagnosis and management challenging. Case presentation: We report the clinical course of an allo-HSCT recipient who developed a rapidly progressive skin rash early after transplantation, and we analyzed the clinical features, histopathology, treatment and outcome. Results: The patient developed rapidly progressive epidermal detachment with severe oral, ocular, and genital mucosal involvement shortly after exposure to trimethoprim\/sulfamethoxazole (TMP-SMX). Disease severity was reflected by a SCORTEN score of 5, corresponding to a very high predicted mortality risk. The clinical picture raised concern for both TEN and severe acute GVHD, while histopathological findings favored TEN but were not definitive. Management included systemic corticosteroids, intravenous immunoglobulin, ruxolitinib, and intensive supportive care. The patient gradually re-epithelialized and recovered without long-term sequelae. Conclusions: This case underscores the diagnostic difficulty of distinguishing TEN from severe acute GVHD in the early post-transplant period. Careful assessment of drug exposure, clinical evolution, and multidisciplinary evaluation are essential to guide timely and appropriate management.<\/jats:p>","DOI":"10.3390\/jcm15124730","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:33:54Z","timestamp":1781768034000},"page":"4730","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Toxic Epidermal Necrolysis Mimicking Severe Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation: A Diagnostic Challenge"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5172-4330","authenticated-orcid":false,"given":"Titas","family":"Ti\u0161kevi\u010dius","sequence":"first","affiliation":[{"name":"Department of Oncology and Hematology, Hospital of Lithuanian University of Health Sciences, Kaunas Clinics, 50161 Kaunas, Lithuania"},{"name":"Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egidija","family":"Kukarskyt\u0117","sequence":"additional","affiliation":[{"name":"Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"},{"name":"Department of Immunology and Allergology, Hospital of Lithuanian University of Health Sciences, Kaunas Clinics, 50161 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignas","family":"Gaidamavi\u010dius","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, Hospital of Lithuanian University of Health Sciences, Kaunas Clinics, 50161 Kaunas, Lithuania"},{"name":"Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Migl\u0117","family":"Kulbok\u0117","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, Hospital of Lithuanian University of Health Sciences, Kaunas Clinics, 50161 Kaunas, Lithuania"},{"name":"Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyna","family":"Beitnerien\u0117","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, Hospital of Lithuanian University of Health Sciences, Kaunas Clinics, 50161 Kaunas, Lithuania"},{"name":"Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u016bta","family":"Dambrauskien\u0117","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, Hospital of Lithuanian University of Health Sciences, Kaunas Clinics, 50161 Kaunas, Lithuania"},{"name":"Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milda","family":"Rud\u017eianskien\u0117","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, Hospital of Lithuanian University of Health Sciences, Kaunas Clinics, 50161 Kaunas, Lithuania"},{"name":"Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima J\u016brat\u0117","family":"Gerbutavi\u010dien\u0117","sequence":"additional","affiliation":[{"name":"Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"},{"name":"Department of Drug Technology and Social Pharmacy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audron\u0117","family":"Vaitiekien\u0117","sequence":"additional","affiliation":[{"name":"Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"},{"name":"Department of Cardiology, Hospital of Lithuanian University of Health Sciences, Kaunas Clinics, 50161 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolandas","family":"Gerbutavi\u010dius","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, Hospital of Lithuanian University of Health Sciences, Kaunas Clinics, 50161 Kaunas, Lithuania"},{"name":"Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9583-4475","authenticated-orcid":false,"given":"Domas","family":"Vaitiekus","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, Hospital of Lithuanian University of Health Sciences, Kaunas Clinics, 50161 Kaunas, Lithuania"},{"name":"Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1093\/jac\/dkw157","article-title":"ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Maertens","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-024-00514-0","article-title":"Severe cutaneous adverse reactions","volume":"10","author":"Hung","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00281-015-0540-2","article-title":"Adverse cutaneous drug eruptions: Current understanding","volume":"38","author":"Hoetzenecker","year":"2016","journal-title":"Semin. Immunopathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","article-title":"Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cells","volume":"114","author":"Nassif","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Sagawa, T., Ishida, T., Jobu, K., Morisawa, S., Akagaki, K., Kato, T., Maruyama, T., Yagi, Y., Kihara, T., and Suzuki, S. (2025). Evaluation of adverse events associated with the sulfamethoxazole\/trimethoprim combination drug. J. Clin. Med., 14.","DOI":"10.3390\/jcm14144819"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/bcp.70051","article-title":"Safety of sulfamethoxazole-trimethoprim for the treatment of bacterial infection in outpatient settings: A systematic review and meta-analysis with active comparator disproportionality analysis","volume":"91","author":"Preyra","year":"2025","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jaci.2022.12.005","article-title":"Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions","volume":"151","author":"Gibson","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1038\/s41467-019-11396-2","article-title":"Identification of drug-specific public TCR driving severe cutaneous adverse reactions","volume":"10","author":"Pan","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"8722","DOI":"10.1038\/s41467-024-52990-3","article-title":"Multiomic single-cell sequencing defines tissue-specific responses in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"15","author":"Gibson","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/bjd.15360","article-title":"Long-term complications of Stevens-Johnson syndrome\/toxic epidermal necrolysis: The spectrum of chronic problems in patients who survive an episode of SJS\/TEN necessitates multidisciplinary follow-up","volume":"177","author":"Lee","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s40257-024-00889-6","article-title":"Update on Stevens-Johnson syndrome and toxic epidermal necrolysis: Diagnosis and management","volume":"25","author":"Shah","year":"2024","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.bmt.1705572","article-title":"Toxic epidermal necrolysis after allogeneic haematopoietic stem cell transplantation","volume":"39","author":"Hilgendorf","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"100011","DOI":"10.1016\/j.allmed.2024.100011","article-title":"Exploring drug-induced toxic epidermal necrolysis: A case series and comprehensive review","volume":"3","author":"Karanam","year":"2025","journal-title":"Allergy Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1172-5-39","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"5","author":"Harr","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/pds.3937","article-title":"Incidence, causative factors and mortality rates of Stevens-Johnson syndrome and toxic epidermal necrolysis in northern Italy: Data from the REACT registry","volume":"25","author":"Diphoorn","year":"2016","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/jamadermatol.2021.3154","article-title":"Assessment of treatment approaches and outcomes in Stevens-Johnson syndrome and toxic epidermal necrolysis: Insights from a Pan-European multicenter study","volume":"157","author":"Kridin","year":"2021","journal-title":"JAMA Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Wang, L., Varghese, S., Bassir, F., Lo, Y.-C., Ortega, C.A., Shah, S., Blumenthal, K.G., Phillips, E.J., and Zhou, L. (2022). Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed\/MEDLINE case reports from 1980 to 2020. Front. Med., 9.","DOI":"10.3389\/fmed.2022.949520"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40257-017-0306-9","article-title":"Cutaneous graft-versus-host disease: Diagnosis and treatment","volume":"19","author":"Knobler","year":"2018","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Yan, H., Mo, Y., Li, Y., Li, Q., Luo, L., Meng, Q., Jia, L., Zhou, L., Xiao, L., and Fu, X. (2025). Management of infection and ocular complications in pediatric SJS\/TEN-like acute graft-versus-host disease: A clinical case study and literature review. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1588297"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1097\/BCR.0000000000000040","article-title":"Extensive toxic epidermal necrolysis versus acute graft versus host disease after allogenic hematopoietic stem-cell transplantation: Challenges in diagnosis and management","volume":"35","author":"Macedo","year":"2014","journal-title":"J. Burn Care Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/pde.15069","article-title":"Toxic epidermal necrolysis-like acute graft-versus-host disease in pediatric bone marrow transplant patients: Case series and review of the literature","volume":"39","author":"Song","year":"2022","journal-title":"Pediatr. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.12788\/cutis.0464","article-title":"Graft-vs-host disease and toxic epidermal necrolysis following hematopoietic stem cell transplantation","volume":"109","author":"Vera","year":"2022","journal-title":"Cutis"},{"key":"ref_23","first-page":"368","article-title":"Graft-versus-host disease variety toxic epidermal necrolysis: Case report","volume":"81","year":"2024","journal-title":"Bol. Med. Hosp. Infant. Mex."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e70117","DOI":"10.1111\/iwj.70117","article-title":"A review on toxic epidermal necrolysis-like superficial wound lesions: Issue and challenge on 10 clinical entities","volume":"21","author":"Rastegarnasab","year":"2024","journal-title":"Int. Wound J."},{"key":"ref_25","first-page":"651590","article-title":"Toxic epidermal necrolysis and graft-versus-host reaction: Revisiting a puzzling similarity","volume":"2013","author":"Paquet","year":"2013","journal-title":"Int. Sch. Res. Not."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jaad.2022.10.035","article-title":"Acute graft-versus-host disease presenting as Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective cohort study","volume":"88","author":"Hung","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Chang, H.C., Wang, T.J., Lin, M.H., and Chen, T.J. (2022). A review of the systemic treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis. Biomedicines, 10.","DOI":"10.3390\/biomedicines10092105"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Yang, L., Shou, Y.H., Li, F., Zhu, X.H., Yang, Y.S., and Xu, J.H. (2022). Intravenous immunoglobulin combined with corticosteroids for the treatment of Stevens-Johnson syndrome\/toxic epidermal necrolysis: A propensity-matched retrospective study in China. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.750173"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Marlowe, E., Palmer, R., Rahrig, A.L., Dinora, D., Harrison, J., Skiles, J., and Rahim, M.Q. (2024). Case report: Toxic epidermal necrolysis as a unique presentation of acute graft versus host disease in a pediatric patient. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1452245"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Zhang, M.Y., Zhao, P., Zhang, Y., and Wang, J.S. (2022). Efficacy and safety of ruxolitinib for steroid-refractory graft-versus-host disease: Systematic review and meta-analysis of randomised and non-randomised studies. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0271979"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Fan, S., Huo, W.X., Yang, Y., Shen, M.Z., and Mo, X.D. (2022). Efficacy and safety of ruxolitinib in steroid-refractory graft-versus-host disease: A meta-analysis. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.954268"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: A severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Fouchard","year":"2000","journal-title":"J. Investig. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1182\/blood-2009-09-242784","article-title":"Graft-versus-host disease: Regulation by microbe-associated molecules and innate immune receptors","volume":"115","author":"Penack","year":"2010","journal-title":"Blood"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Gomulka, J., Wilson, B.D., and Joyce, J.C. (2014). Toxic epidermal necrolysis due to voriconazole: Case report and review. Dermatol. Online J., 20.","DOI":"10.5070\/D3209023901"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1080\/10428194.2017.1422867","article-title":"Toxic epidermal necrolysis versus cutaneous graft-versus-host disease in a hematopoietic stem cell transplant recipient: The role of elafin","volume":"59","author":"Chen","year":"2018","journal-title":"Leuk. Lymphoma"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s12185-019-02675-1","article-title":"Complete response following toxic epidermal necrolysis in relapsed adult T cell leukemia\/lymphoma after haploidentical stem cell transplantation","volume":"110","author":"Morishige","year":"2019","journal-title":"Int. J. Hematol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5603\/ahp.100540","article-title":"Toxic epidermal necrolysis after allogeneic hematopoietic stem cell transplantation for refractory Hodgkin\u2019s lymphoma","volume":"55","author":"Chromik","year":"2024","journal-title":"Acta Haematol. Pol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4730\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:09:50Z","timestamp":1781770190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["jcm15124730"],"URL":"https:\/\/doi.org\/10.3390\/jcm15124730","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]}}}